Open AccessPoor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia
Author(s) -
Robert C. Welliver,
Lydia Feinstein,
Julia B. Ward,
Ziya Kırkalı,
Erline Martinez-Miller,
Brian R. Matlaga,
Kevin T. McVary
Publication year - 2021
Publication title -
prostate cancer and prostatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2
H-Index - 64
eISSN - 1476-5608
pISSN - 1365-7852
DOI - 10.1038/s41391-021-00435-z
Subject(s) - medicine , lower urinary tract symptoms , urinalysis , prostate cancer , incidence (geometry) , guideline , prostate specific antigen , benign prostatic hyperplasia (bph) , cohort , bladder cancer , urology , gynecology , urinary system , cancer , prostate , pathology , physics , optics
The American Urological Association makes recommendations for evaluation and testing for lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) to help primary care providers and specialists identify LUTS/BPH and harmful related conditions including urinary retention and prostate or bladder cancer. Our understanding of provider adherence to these Guidelines is limited to single-site or nonrepresentative settings.